The Role of Apalutamide in Patients with Metastatic Castration-Sensitive Prostate Cancer

Neeraj Agarwal, MD, and Simon Chowdhury, MD, review final results from the TITAN study of apalutamide in patients with mCSPC and discuss the clinical implications of the findings.